Farmacologia delle disfunzioni sessuali maschili.

Translated title of the contribution: Pharmacology of male sexual dysfunction

A. Aversa, M. Rocchietti-March, D. Botta, M. Caprio, P. Pezzella, E. Fabbrini, A. Fabbri, V. Bonifacio

Research output: Contribution to journalArticlepeer-review


The understanding of pharmacology of impotence has shown a steady improvement over the last 15 years which has resulted in a better appreciation of the neurovascular mechanisms of the erectile process especially at the level of the corpora cavernosa; however, central mechanisms which control libido and erection are not yet completely elucidated. Frequent diseases most commonly encountered in elderly patients--i.e. diabetes, hypertension, atherosclerosis, depression, etc--represent a frequent cause of erectile dysfunction (ED) and are treated with medications that can interfere with sexual functioning at the central and/or peripheral level. Antidepressants, including the tricyclics and the monoamine oxidase inhibitors, have been implicated in ED, decreased libido, and impaired ejaculation. Most antihypertensives have been associated with some erectile impairment, but diuretics seem to have little effect on erectile function. The calcium channel blockers and ACE inhibitors are associated with a low incidence of ED. Sympatholytic antihypertensives seldom cause importence but can cause retrograde ejaculation because of the relaxation of the smooth muscles in the prostatic urethra and bladder neck. The most commonly prescription drugs that can affect sexual function are briefly discussed and an integrated pharmacological approach to the patient with drug-induced ED is proposed.

Translated title of the contributionPharmacology of male sexual dysfunction
Original languageItalian
Pages (from-to)17-25
Number of pages9
JournalMinerva Endocrinologica
Issue number1
Publication statusPublished - 1998


Dive into the research topics of 'Pharmacology of male sexual dysfunction'. Together they form a unique fingerprint.

Cite this